FDA Inspection
Paul W. Wallace, MDPaul W. Wallace, MD – FDA Inspection, Mar 17, 2026
Record Details
This FDA Inspection record concerns Paul W. Wallace, MD, with an inspection on March 17, 2026, issued by the Los Angeles District Office, covering human drugs.
View Company Profile
ID · f6ed70f6-0bc5-4521-9c11-8fcd6786192e
Inspection Facts
- Inspection number
- 1307736
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Paul W. Wallace, MD
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 16, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 8, 2018 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Paul W. Wallace, MD
- FDA Inspection 1208694 - 2023-06-16
- FDA Inspection 1055969 - 2018-06-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.